By Counterforce Health Team in Elaprase (idursulfase) —

How to Get Elaprase (idursulfase) Covered by Cigna in Illinois: Complete Requirements Checklist and Appeal Guide

Answer Box: Getting Elaprase Covered by Cigna in Illinois

Elaprase (idursulfase) requires prior authorization from Cigna in Illinois, with approval typically taking 5 business days when complete documentation is submitted. The fastest path involves three steps: (1) Submit electronic PA through CoverMyMeds or Surescripts with enzymatic/genetic confirmation of Hunter syndrome, (2) Include weight-based dosing calculations (0.5 mg/kg weekly) and specialist attestation, and (3) If denied, file internal appeal within 180 days, then automatic external review through Illinois Department of Insurance. Start today by gathering your Hunter syndrome diagnostic test results and current weight documentation.

Table of Contents

  1. Who Should Use This Checklist
  2. Member & Plan Basics
  3. Clinical Criteria Requirements
  4. Coding and Documentation Essentials
  5. Your Documentation Packet
  6. Submission Process
  7. Specialty Pharmacy Coordination
  8. After Submission: What to Expect
  9. Appeals Process in Illinois
  10. Common Denial Reasons & Solutions
  11. Costs and Financial Assistance
  12. FAQ

Who Should Use This Checklist

This guide is for Illinois residents with Hunter syndrome (MPS II) who need Elaprase (idursulfase) covered by Cigna. You'll find this most helpful if you're:

  • Newly diagnosed and starting enzyme replacement therapy
  • Facing a Cigna denial for Elaprase
  • Switching from another insurer to Cigna
  • Moving to Illinois from another state
  • Experiencing quantity limit restrictions

Expected outcome: With complete documentation, most medically appropriate Elaprase requests receive approval. Illinois patients have strong appeal rights, including automatic external review for medical necessity denials starting in 2025.

Member & Plan Basics

Coverage Verification Checklist

✅ Active Cigna coverage (check member portal or call member services)
✅ Specialty drug benefits included in your plan
✅ Deductible status (high-deductible plans may require meeting deductible first)
✅ Plan type confirmed (commercial, Medicare Advantage, or Medicaid managed care)

Note: Cigna typically manages specialty drugs like Elaprase through Express Scripts/Accredo specialty pharmacy networks.

Authorization Requirements

All Cigna plans require prior authorization for Elaprase. There are no step therapy requirements since Elaprase is the only FDA-approved enzyme replacement therapy for Hunter syndrome.

Clinical Criteria Requirements

Primary Diagnosis Requirements

Hunter syndrome (MPS II) must be confirmed with:

  1. Enzymatic testing: Decreased iduronate 2-sulfatase (I2S) enzyme activity in blood or leukocytes
  2. Genetic confirmation: Pathogenic variant in the IDS gene identified through sequencing
  3. Clinical documentation: Symptoms consistent with MPS II

Dosing and Duration Standards

  • Standard dose: 0.5 mg/kg body weight weekly via IV infusion
  • Quantity limits: Most plans allow up to 240 mg per 28 days
  • Duration: Initial authorization typically 12 months with annual renewal

Specialist Requirements

Cigna often requires the prescription be written by or in consultation with a physician experienced in treating lysosomal storage disorders.

Coding and Documentation Essentials

Required Codes

Code Type Code Description
ICD-10 E76.1 Mucopolysaccharidosis, type II (Hunter syndrome)
HCPCS J-Code J1743 Injection, idursulfase, 1 mg
NDC 54092-700-01 Elaprase 2 mg/mL, 3 mL vial
CPT (Administration) 96365 IV infusion, initial hour
CPT (Additional) 96366 Each additional hour

Documentation Requirements

Patient demographics:

  • Full name, date of birth, address
  • Cigna member ID number
  • Prescribing physician information

Clinical documentation:

  • Hunter syndrome diagnosis with ICD-10 code
  • Enzymatic test results showing I2S deficiency
  • Genetic test results confirming IDS gene mutation
  • Current weight for dosing calculations
  • Treatment goals and monitoring plan

Your Documentation Packet

Medical Necessity Letter Components

Your physician should include:

  1. Patient identification and diagnosis confirmation
  2. Diagnostic test results (enzymatic and genetic)
  3. Clinical presentation and disease severity
  4. Treatment rationale for Elaprase
  5. Dosing justification based on current weight
  6. Monitoring plan including infusion safety protocols
  7. Expected outcomes and treatment goals

Required Attachments

✅ Laboratory reports: I2S enzyme activity results
✅ Genetic test results: IDS gene sequencing report
✅ Recent clinical notes documenting current status
✅ Growth charts/weight documentation for pediatric patients
✅ Infusion center information if applicable

From our advocates: We've seen the strongest approvals when families include a one-page timeline showing diagnostic journey and current clinical status. This helps reviewers quickly understand the medical necessity without searching through multiple documents.

Submission Process

Electronic Submission (Preferred)

Submit through Cigna's preferred portals:

Required Information for Submission

  1. Patient demographics (name, DOB, address, Cigna ID)
  2. Prescriber information and NPI number
  3. Diagnosis code (E76.1) with supporting documentation
  4. Requested dose and frequency with weight-based calculations
  5. Duration of therapy requested
  6. Supporting clinical documentation

Timeline Expectations

  • Standard review: 5 business days
  • Expedited review: 24-72 hours (call Cigna to request)
  • Incomplete submissions: May take longer due to additional information requests

Specialty Pharmacy Coordination

Cigna's Preferred Networks

Cigna typically requires Elaprase to be dispensed through:

  • Express Scripts Specialty Pharmacy
  • Accredo Specialty Pharmacy

Transfer Process

  1. Obtain PA approval first
  2. Contact specialty pharmacy to initiate transfer
  3. Verify shipment details and infusion center coordination
  4. Confirm delivery schedule aligned with treatment plan

After Submission: What to Expect

Tracking Your Request

  • Confirmation number: Record this when submitting
  • Status checks: Use Cigna member portal or call member services
  • Response timeline: 5 business days for standard review

Possible Outcomes

Approved: Prescription forwarded to specialty pharmacy
Denied: Proceed to appeals process (see below)
Pending: Additional information requested - respond promptly

Appeals Process in Illinois

Illinois residents have exceptionally strong appeal rights under the Health Carrier External Review Act.

Internal Appeal Process

Timeline: File within 180 days of denial
Decision: Cigna must respond within 15 business days
Expedited: 24 hours for urgent cases

Automatic External Review (New for 2025)

Starting April 2025, all medical necessity denials upheld on internal appeal automatically proceed to external review unless you opt out. This dramatically improves approval rates for rare disease medications.

Key features:

  • No additional filing required
  • Specialist reviewer with Hunter syndrome expertise
  • 5-day decision after medical records received
  • Binding on Cigna with enforcement penalties up to $50,000

Illinois Resources

  • Illinois Department of Insurance: File external review
  • Consumer hotline: 877-527-9431
  • Attorney General Health Care Helpline: 1-877-305-5145

Common Denial Reasons & Solutions

Denial Reason Solution
Missing enzymatic confirmation Submit I2S enzyme activity test results
No genetic testing Provide IDS gene sequencing report
Incorrect dosing Recalculate based on current weight (0.5 mg/kg)
Quantity limit exceeded Justify higher dose with weight documentation
Missing specialist attestation Obtain letter from lysosomal storage disorder specialist
Incomplete clinical notes Submit comprehensive progress notes showing medical necessity

Costs and Financial Assistance

Manufacturer Support

Takeda Patient Services offers:

  • Copay assistance programs
  • Patient access support
  • Reimbursement guidance

Contact: Takeda Patient Services (verify current contact information)

Foundation Grants

  • National Organization for Rare Disorders (NORD)
  • EveryLife Foundation
  • Patient Advocate Foundation

Illinois-Specific Programs

Illinois Medicaid covers Elaprase for eligible patients. Contact Illinois Department of Healthcare and Family Services for eligibility information.

FAQ

Q: How long does Cigna prior authorization take in Illinois?
A: Standard review is 5 business days. Expedited review (for urgent cases) is 24-72 hours.

Q: What if Elaprase is not on Cigna's formulary?
A: Request a formulary exception with strong clinical justification. Since there's no alternative therapy, approval rates are typically high.

Q: Can I appeal if my dose exceeds quantity limits?
A: Yes. Provide current weight documentation and dosing calculations showing medical necessity for the higher amount.

Q: What happens if Cigna denies my internal appeal?
A: Starting in 2025, your case automatically goes to external review by an independent specialist unless you opt out.

Q: How quickly must I file an appeal in Illinois?
A: Internal appeal within 180 days of denial. External review happens automatically after internal appeal denial.

Q: Does step therapy apply to Elaprase?
A: No. Elaprase is the only FDA-approved enzyme replacement therapy for Hunter syndrome, so no step therapy requirements apply.

Counterforce Health helps patients, clinicians, and specialty pharmacies turn insurance denials into targeted, evidence-backed appeals. Our platform analyzes denial letters and plan policies to draft point-by-point rebuttals aligned with payer requirements, pulling the right clinical evidence and regulatory citations to strengthen your case. Visit CounterforceHealth.org to learn how we're helping families navigate complex prior authorization and appeals processes.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance coverage policies change frequently. Always verify current requirements with your insurer and consult healthcare professionals for medical decisions. For personalized assistance with Illinois insurance appeals, contact the Illinois Department of Insurance at 877-527-9431.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.